Authored by: Ye Yongqing (Bill) , Yu Yue (Jessie) , Wang Yixiao and Tan Tian
Recently, the ongoing anti-corruption campaign in the healthcare industry across the nation has been increasingly intensified. The anti-corruption campaign primarily targets the distribution sector of medical industry, and medical companies are faced with the pressure of compliance system building and risk assessments with regard to medical distribution process. Against this backdrop, tax compliance, compared to the liabilities that may arise from non-compliant marketing practices, is often overlooked by medical companies and becomes a covert weakness in the entire medical compliance system.